Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omexa Sumatriptan Sublingual vs Imitrex Oral Bioavailability
NCT02954276Phase 1Unknown
- Sponsor
- Targia Pharmaceuticals Ltd
- Start
- Mar 2016
- Primary completion
- Aug 2016
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of sumatriptan in migraine (2 arms), sponsored by Targia Pharmaceuticals Ltd. Primary endpoints: Time to reach peak plasma concentration, Peak Plasma concentration and 1 more. Status: unknown.
02
Drugs
sumatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02954276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02954276.